Evidence map›Paper›PMID 30167718›Full record

ReviewHNO2019

[Immunology of chronic rhinosinusitis with nasal polyps as a basis for treatment with biologicals].

L Klimek, M Koennecke, J Hagemann, B Wollenberg, S Becker

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in HNO, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07675512 (Effect of Adelmidrol Nasal Spray on Chronic Rhinosinusitis With Nasal Polyps), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07675512 nacompletednot on this mapstarted 2025, after this paper: background citation

Effect of Adelmidrol Nasal Spray on Chronic Rhinosinusitis With Nasal Polyps: A Randomized Controlled Study Evaluating Clinical, Endoscopic, and Radiological Outcomes Before and After Functional Endoscopic Sinus Surgery (FESS)

TypeinterventionalSponsorUniversity of Campania Luigi VanvitelliRan2025 to 2026Enrolled60ConditionsChronic Sinusitis With Nasal PolypsArmsAdelmidrol spray -Rinidrol, Nasonex Nasal Spray, Nasonex Nasal Spray + Rinidrol
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Allergo Journal : interdisziplinare Zeitschrift fur Allergologie und Umweltmedizin : Organ der Deutschen Gesellschaft fur Allergie- und Immunitatsforschung · 2022
    Review
  7. Laryngo- rhino- otologie · 2020
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

L KlimekZentrum für Rhinologie und Allergologie, An den Quellen 10, 65183, Wiesbaden, Deutschland. Ludger.Klimek@Allergiezentrum.org.
M KoenneckeKlinik für Hals‑, Nasen- und Ohrenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.
J HagemannHals‑, Nasen‑, Ohrenklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55101, Mainz, Deutschland.
B WollenbergKlinik für Hals‑, Nasen- und Ohrenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland.
S BeckerHals‑, Nasen‑, Ohrenklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55101, Mainz, Deutschland.
Johannes Gutenberg University Mainz · DEUniversitätsklinik für Hals-, Nasen- und Ohrenheilkunde · DEUniversity Hospital Schleswig-Holstein · DEZentrum für Rhinologie und Allergologie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic rhinosinusitis (CRS) is a heterogeneous and multifactorial inflammation of the nasal and paranasal mucosa. Until now, no internationally standardized classification could be developed. In most cases, CRS is phenotypically classified according to chronic rhinosinusitis with (CRScNP) and without nasal polyps (CRSsNP). However, recent studies could show that there are numerous endotypes within these phenotypes based on different inflammatory mechanisms. This review describes the important immunological mechanisms of CRScNP and highlights modern treatment options with biologicals directly addressing particular immunological processes.

methodsCurrent knowledge on immunological and molecular processes of CRS, particularly CRScNP, was extracted from Medline, PubMed, national and international study- and guideline-registers, and the Cochrane library by a systematic review of the literature.

resultsBased on current literature, various immunological mechanisms for CRS and CRScNP could be identified. Relevant studies for the treatment of eosinophilic conditions such as asthma or CRScNP are presented and, if available, results of these studies are discussed.

conclusionThe growing insight into the underlying immunological mechanisms of CRScNP could pave the way for new personalized treatment options such as biologicals in the future.

Indexed as

Biological ProductsChronic DiseaseHumansNasal PolypsRhinitisSinusitisBiological ProductsAsthmaCRScNPInflammationMucous membraneSinusitis

Identifiers

PMID30167718
OpenAlexW2889163467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.